Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Hooper

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 11, 2023
Letter to the Editor From Hooper: "Cardio-cerebrovascular Outcomes in Maturity Onset Diabetes of the Young, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study"Amanda J Hooper
The Clinical Biochemist. Reviews|June 21, 2008
Common and rare gene variants affecting plasma LDL cholesterolJohn R Burnett, Amanda J Hooper
The New England Journal of Medicine|November 29, 2018
PCSK9 - A Journey to Cardiovascular OutcomesJohn R Burnett, Amanda J Hooper
Current Opinion in Lipidology|December 21, 2012
Recent developments in the genetics of LDL deficiencyAmanda J Hooper, John R Burnett
Current Atherosclerosis Reports|May 1, 2014
Update on primary hypobetalipoproteinemiaAmanda J Hooper, John R Burnett
Expert Opinion on Investigational Drugs|June 26, 2012
Dalcetrapib , a cholesteryl ester transfer protein modulatorAmanda J Hooper, John R Burnett
Expert Opinion on Biological Therapy|December 18, 2012
Anti-PCSK9 therapies for the treatment of hypercholesterolemiaAmanda J Hooper, John R Burnett
Lancet (London, England)|October 8, 2013
Running interference to lower cholesterolJohn R Burnett, Amanda J Hooper
Clinical Chemistry|November 14, 2014
Sorting the wheat from the chaff in familial hypercholesterolemiaAmanda J Hooper, Gerald F Watts
Current Opinion in Molecular Therapeutics|January 15, 2010
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiencyJohn R Burnett, Amanda J Hooper
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|December 11, 2023
Letter to the Editor From Hooper: "Cardio-cerebrovascular Outcomes in Maturity Onset Diabetes of the Young, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study"Amanda J Hooper
The Clinical Biochemist. Reviews|June 21, 2008
Common and rare gene variants affecting plasma LDL cholesterolJohn R Burnett, Amanda J Hooper
The New England Journal of Medicine|November 29, 2018
PCSK9 - A Journey to Cardiovascular OutcomesJohn R Burnett, Amanda J Hooper
Current Opinion in Lipidology|December 21, 2012
Recent developments in the genetics of LDL deficiencyAmanda J Hooper, John R Burnett
Current Atherosclerosis Reports|May 1, 2014
Update on primary hypobetalipoproteinemiaAmanda J Hooper, John R Burnett
Expert Opinion on Investigational Drugs|June 26, 2012
Dalcetrapib , a cholesteryl ester transfer protein modulatorAmanda J Hooper, John R Burnett
Expert Opinion on Biological Therapy|December 18, 2012
Anti-PCSK9 therapies for the treatment of hypercholesterolemiaAmanda J Hooper, John R Burnett
Lancet (London, England)|October 8, 2013
Running interference to lower cholesterolJohn R Burnett, Amanda J Hooper
Clinical Chemistry|November 14, 2014
Sorting the wheat from the chaff in familial hypercholesterolemiaAmanda J Hooper, Gerald F Watts
Current Opinion in Molecular Therapeutics|January 15, 2010
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiencyJohn R Burnett, Amanda J Hooper
Pageof 13